Avinger to Announce Fourth Quarter and Full Year 2016 Results on March 6, 2017
21 févr. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that it will...
Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease
25 janv. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif. and LEIPZIG, Germany, Jan. 25, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today...
Avinger Announces Presentations Showcasing Lumivascular Technology at Leipzig Interventional Course
19 janv. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...
Avinger Announces Preliminary Fourth Quarter 2016 Results
06 janv. 2017 07h30 HE
|
Avinger Inc
REDWOOD CITY, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that based on...
Avinger Announces New FDA Clearance for Lumivascular Imaging Console, Enabling Vessel Measurement Via Touchscreen
22 déc. 2016 07h30 HE
|
Avinger Inc
Technology Upgrade to Lightbox L250 Allows Physicians to Accurately Assess Luminal Gain REDWOOD CITY, Calif., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of...
Avinger Announces Third Quarter 2016 Results
03 nov. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger to Present at Upcoming Investor Conferences
27 oct. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the Company...
Avinger Launches Upgraded Lightbox Imaging Console
25 oct. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the U.S....
Avinger to Announce Third Quarter 2016 Results on Thursday, November 3, 2016
24 oct. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger Announces Schedule of Sessions Highlighting Lumivascular Technology at TCT 2016
20 oct. 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...